Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELEGILINE vs SELPERCATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELEGILINE vs SELPERCATINIB: Safety Overview

Metric SELEGILINE SELPERCATINIB
Total FAERS Reports 932 1,084
Deaths Reported 36 160
Death Rate 3.9% 14.8%
Hospitalizations 199 342
Average Patient Age 58.7 yrs 63.0 yrs
% Female Patients 57.4% 56.7%
FDA Approval Date Apr 1, 1997 Apr 10, 2024
Manufacturer Bausch Health US, LLC Eli Lilly and Company
Route ORAL ORAL
Marketing Status Discontinued Prescription